Human Cytomegalovirus Resistance to Antiviral Drugs

This publication has 156 references indexed in Scilit:

• Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response
  Journal of Antimicrobial Chemotherapy, 2004
• Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient1
  Transplantation, 2003
• Susceptibilities of Human Cytomegalovirus Clinical Isolates to BAY38-4766, BAY43-9695, and Ganciclovir
  Antimicrobial Agents and Chemotherapy, 2001
• Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein*
  Journal of Medical Virology, 2001
• Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
  New England Journal of Medicine, 1999
• Cytomegalovirus UL97 and Glycoprotein B (gB) Sequences in Tissues from Immunocompromised Patients with Ganciclovir-resistant Virus Infection
  Scandinavian Journal of Infectious Diseases, 1999
• Herpes Simplex Virus Type 1 DNA Polymerase
  Journal of Biological Chemistry, 1996
• Foscarnet
  Drugs, 1991
• Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients
  New England Journal of Medicine, 1989
• Screening with a shell vial assay for antiviral activity against cytomegalovirus
  Diagnostic Microbiology and Infectious Disease, 1989